Jeffrey R. Stokes

Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial

Daniel J. Jackson, Leonard B. Bacharier, Peter J. Gergen et al. · The Lancet · 2022 · 147 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +15

Eosinophilic Asthma

Ryan K. Nelson, Andrew Bush, Jeffrey R. Stokes et al. · The Journal of Allergy and Clinical Immunology In Practice · 2019 · 86 citations

Identifying Efficient Dairy Producers Using Data Envelopment Analysis

Jeffrey R. Stokes, Peter R. Tozer, Jeffrey Hyde · Journal of Dairy Science · 2007 · 77 citations · Full text

Agriculture, Dairy Science, Economics +8

Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation

Wanda Phipatanakul, David T. Mauger, Theresa W. Guilbert et al. · Contemporary Clinical Trials · 2020 · 64 citations · Full text

Medicine, Child Health, Preventive Medicine +10

The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms

Jeffrey R. Stokes, F.A. Romero, Richard Allan et al. · Journal of Allergy and Clinical Immunology · 2011 · 58 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14